Results 331 to 340 of about 9,606,287 (373)
Some of the next articles are maybe not open access.
Seminars in Neurology, 2009
Neuromuscular diseases are a broadly defined group of disorders that all involve injury or dysfunction of peripheral nerves or muscle. The site of injury can be in the cell bodies (i.e., amyotrophic lateral sclerosis [ALS] or sensory ganglionopathies), axons (i.e., axonal peripheral neuropathies or brachial plexopathies), Schwann cells (i.e., chronic ...
B. Morrison
openaire +3 more sources
Neuromuscular diseases are a broadly defined group of disorders that all involve injury or dysfunction of peripheral nerves or muscle. The site of injury can be in the cell bodies (i.e., amyotrophic lateral sclerosis [ALS] or sensory ganglionopathies), axons (i.e., axonal peripheral neuropathies or brachial plexopathies), Schwann cells (i.e., chronic ...
B. Morrison
openaire +3 more sources
Pediatric Neuromuscular Diseases
Pediatric Neurology, 2023The diagnostic and referral workflow for children with neuromuscular disorders is evolving, particularly as newborn screening programs are expanding in tandem with novel therapeutic developments. However, for the children who present with symptoms and signs of potential neuromuscular disorders, anatomic localization, guided initially by careful history
Geetanjali Rathore, Peter B. Kang
openaire +2 more sources
MRI in Neuromuscular Diseases: An Emerging Diagnostic Tool and Biomarker for Prognosis and Efficacy
Annals of Neurology, 2020There is an unmet need to identify biomarkers sensitive to change in rare, slowly progressive neuromuscular diseases. Quantitative magnetic resonance imaging (MRI) of muscle may offer this opportunity, as it is noninvasive and can be carried out almost ...
J. Dahlqvist +3 more
semanticscholar +1 more source
Hereditary neuromuscular diseases
European Journal of Radiology, 2001This article presents the actual classification of neuromuscular diseases based on present expansion of our knowledge and understanding due to genetic developments. It summarizes the genetic and clinical presentations of each disorder together with CT findings, which we studied in a large group of patients with neuromuscular diseases.
Özsarlak, Ö. +6 more
openaire +3 more sources
Muscle and Nerve, 2020
While traditional immunosuppressive and immunomodulatory therapies remain the cornerstone of immune‐mediated neuromuscular disease management, new and novel agents including antigen‐specific, monoclonal antibody drugs, have emerged as important treatment
C. Farmakidis +3 more
semanticscholar +1 more source
While traditional immunosuppressive and immunomodulatory therapies remain the cornerstone of immune‐mediated neuromuscular disease management, new and novel agents including antigen‐specific, monoclonal antibody drugs, have emerged as important treatment
C. Farmakidis +3 more
semanticscholar +1 more source
2016
Abstract Types of myopathy, myotonia, and muscular dystrophy are discussed. Neuromuscular junction disorders such as myasthenia gravis, Lambert-Eaton syndrome, and botulism are discussed also. Guillain-Barré syndrome and its variants are described. Motor neuron diseases, such as amyotrophic lateral sclerosis, are discussed.
Robert J. Gatchel +3 more
openaire +2 more sources
Abstract Types of myopathy, myotonia, and muscular dystrophy are discussed. Neuromuscular junction disorders such as myasthenia gravis, Lambert-Eaton syndrome, and botulism are discussed also. Guillain-Barré syndrome and its variants are described. Motor neuron diseases, such as amyotrophic lateral sclerosis, are discussed.
Robert J. Gatchel +3 more
openaire +2 more sources
Autoimmunity in Neuromuscular Disease
Annals of the New York Academy of Sciences, 1987SUMMARY AND CONCLUSIONSA number of confounding factors can be identified from the search for autoimmune mechanisms over the last 2 decades that may be relevant for future studies. (1) An apparently homogeneous clinical disorder may represent more than one disease process and thereby imply antibody/antigen heterogeneity as, for example, in MG with and ...
openaire +2 more sources
Health maintenance for adults with neuromuscular diseases on immunosuppression
Muscle and Nerve, 2019Immunosuppressants are commonly used in the treatment of neuromuscular diseases. The use of these medications requires health maintenance screening and monitoring for multiple potential sides effects, which may be best conducted when the prescribing ...
S. Cartwright, M. Cartwright
semanticscholar +1 more source
How useful is muscle ultrasound in the diagnostic workup of neuromuscular diseases?
Current Opinion in Neurology, 2018Purpose of review This review focuses on developments in muscle ultrasound as a noninvasive and accurate tool for the diagnosis and follow-up of neuromuscular disease. It discusses current muscle ultrasound applications with already proven clinical value,
N. van Alfen +2 more
semanticscholar +1 more source